CN101612233A - A kind of Chinese medicine preparation of reducing swelling and alleviating pain - Google Patents
A kind of Chinese medicine preparation of reducing swelling and alleviating pain Download PDFInfo
- Publication number
- CN101612233A CN101612233A CN200910017181A CN200910017181A CN101612233A CN 101612233 A CN101612233 A CN 101612233A CN 200910017181 A CN200910017181 A CN 200910017181A CN 200910017181 A CN200910017181 A CN 200910017181A CN 101612233 A CN101612233 A CN 101612233A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- alleviating pain
- reducing swelling
- medicine preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses a kind of Chinese medicine preparation of reducing swelling and alleviating pain, raw material composition and the weight proportion thereof of making this effective ingredient are: Radix Salviae Miltiorrhizae 4.5-5.5kg, Rhizoma Corydalis 2-3kg, Radix Angelicae Sinensis 0.5kg, Radix Notoginseng 0.375kg, Radix Paeoniae Rubra 4.5-5.5kg, Pericarpium Citri Reticulatae Viride 0.5kg, Radix Aucklandiae 2-3kg, eupolyphaga 2-3kg, Borneolum Syntheticum 0.125kg.The said preparation processing technology is simple, and cost is low, and medication is convenient, is used for the treatment of soft tissue injury, and effect is good.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation of reducing swelling and alleviating pain.
Background technology
Soft tissue injury belongs to traditional Chinese medical science muscle and tendon injury category, and its pathology traditional Chinese medical science thinks that external force injures meridians, and meridians are obstructed, QI-blood circulation imbalance, and impairment of QI is pain then, and row is hindered then swollen, so be cardinal symptom to swell and ache.Need blood circulation promoting and blood stasis dispelling, regulating QI to relieve pain during treatment.The present invention is on the basis of theory of Chinese medical science, through allotment and experiment are made for a long time.
Summary of the invention
Purpose of the present invention is exactly the pure Chinese medicinal preparation that a kind of reducing swelling and alleviating pain will be provided, and is used for soft tissue injury swelling pain treatment of conditions and alleviation, good effect, and expense is low.
In order to realize the foregoing invention purpose, characteristics of the present invention are that raw material composition and the weight proportion thereof of making this effective ingredient are: Radix Salviae Miltiorrhizae 4.5-5.5kg, Rhizoma Corydalis 2-3kg, Radix Angelicae Sinensis 0.5kg, Radix Notoginseng 0.375kg, Radix Paeoniae Rubra 4.5-5.5kg, Pericarpium Citri Reticulatae Viride 0.5kg, Radix Aucklandiae 2-3kg, eupolyphaga 2-3kg, Borneolum Syntheticum 0.125kg.
Preferred prescription of the present invention is that raw material composition and the weight proportion thereof of making this effective ingredient are: Radix Salviae Miltiorrhizae 5kg, Rhizoma Corydalis 2.5kg, Radix Angelicae Sinensis 0.5kg, Radix Notoginseng 0.375kg, Radix Paeoniae Rubra 5kg, Pericarpium Citri Reticulatae Viride 0.5kg, Radix Aucklandiae 2.5kg, eupolyphaga 2.5kg, Borneolum Syntheticum 0.125kg.
The preparation method of the Chinese medicine preparation of reducing swelling and alleviating pain provided by the present invention is: wait decoction pieces to mix by going up of the Chinese medicine of respectively distinguishing the flavor of in the selected prescription of above-mentioned weight proportion relation, under aseptic condition, dry, be ground into granularity and be the powder more than 120 orders, be distributed into capsule then.
Usage and dosage of the present invention is: oral every day three times, and each 1.5-1.8g, also available in addition vinegar is transferred the medicamental pulverata external application, and it is better that Orally taken and externally share effect.
Radix Salviae Miltiorrhizae among the present invention, Rhizoma Corydalis, Radix Angelicae Sinensis, Radix Notoginseng, Radix Paeoniae Rubra, eupolyphaga have the effect of blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, and wherein Radix Salviae Miltiorrhizae has also that relieving restlessness is calmed the nerves and the effect of removing heat from blood; Rhizoma Corydalis has circulation of qi promoting concurrently; Radix Notoginseng is not only invigorated blood circulation but also stop blooding, and removes the blood of the resistance of becoming silted up, and ends the blood of outflow; The Radix Aucklandiae, Pericarpium Citri Reticulatae Viride regulating QI to relieve pain, the capable then blood of gas is capable; The arduous GUIXIN Liver Channel that is slightly cold of Borneolum Syntheticum has the refreshment of having one's ideas straightened out, heat clearing away antisepsis.The complete square effect that can arrive blood circulation promoting and blood stasis dispelling, regulating QI to relieve pain of gathering altogether with the effect of the refreshment of having one's ideas straightened out, relieving restlessness, is used for the treatment of soft tissue injury simultaneously, and effect is good.Processing technology of the present invention is simple, and cost is low, and medication is convenient, is particularly suitable for the relatively poor extensive patients of China's rural area medical condition.
The invention has the advantages that:
1. effect is good.
2. make simply, only need oven dry, pulverizing and powdery, help Chinese medicine popularizing in basic unit.
3. cheap, alleviated the problem of patient's high cost of getting medical treatment.For example: the patient of same soft tissue injury disappears from the swelling pain of taking medicine, and the capsule that clothes the present invention makes only needs 20 yuan, and the three seven kinds of impairments sheets that the illustrious and influential Pharmaceutical in clothes Tangshan is produced need 39 yuan.
4. without any side effects.
The clinical experiment result: 100 patients of picked at random, wherein male 56 people, women 44 people maximum 69 years old, minimum 1 years old, 36 years old mean age, are divided into treatment group (male 28 people, women 22 people) and matched group (male 28 people, women 22 people).Oral capsule preparations of the present invention is organized in treatment, the oral three seven kinds of impairments sheets of matched group.For the ease of comparing, swelling and pain respectively are divided into three grades: the one-level local swelling, but tension force is not high; Secondary swelling tension force height; Three grades of swelling have tension force water; One-level pain can be stood; Secondary pain need be taken the painful medicine in town; Still feel pain behind three grades of painful medicines in clothes town.In the therapeutic process, the meansigma methods of getting curative effect is depicted as the swelling curve chart and the pain curve chart (seeing Fig. 1 and Fig. 2 of Figure of description) of treatment group and matched group.
By swelling curve chart and pain curve chart, can clearly find out, the treatment group still is that therapeutic effect aspect the pain all is better than matched group than matched group in swelling, especially effect is more outstanding aspect alleviating pain, and its reason is to regulate the flow of vital energy qi being the governor of blood in the prescription with the Radix Aucklandiae, Pericarpium Citri Reticulatae Viride, the capable then blood of gas is capable, impairment of QI is pain then, and gas is along then disappearing bitterly, so relieving pain.
Description of drawings
Fig. 1 is the swelling curve chart of treatment group and matched group;
Fig. 2 is the pain curve chart of treatment group and matched group.
The specific embodiment
The decoction pieces that go up to wait that takes by weighing following traditional Chinese medicines by proportion relation mixes, Radix Salviae Miltiorrhizae 5Kg wherein, Rhizoma Corydalis 2.5Kg, Radix Angelicae Sinensis 0.5Kg, Radix Notoginseng 0.375Kg, Radix Paeoniae Rubra 5Kg, Pericarpium Citri Reticulatae Viride 0.5Kg, Radix Aucklandiae 2.5Kg, eupolyphaga 2.5Kg, Borneolum Syntheticum 0.125Kg.Drying and be ground into granularity after mixing under aseptic condition is 120 purpose powder, is distributed into capsule then, and every capsules is equipped with medicamental pulverata 0.3g.
The decoction pieces that go up to wait that takes by weighing following traditional Chinese medicines by proportion relation mixes, Radix Salviae Miltiorrhizae 4.5Kg wherein, Rhizoma Corydalis 2Kg, Radix Angelicae Sinensis 0.5Kg, Radix Notoginseng 0.375Kg, Radix Paeoniae Rubra 5.5Kg, Pericarpium Citri Reticulatae Viride 0.5Kg, Radix Aucklandiae 2Kg, eupolyphaga 3Kg, Borneolum Syntheticum 0.125Kg.Drying and be ground into granularity after mixing under aseptic condition is 120 purpose powder, is distributed into capsule then, and every capsules is equipped with medicamental pulverata 0.3g.
The decoction pieces that go up to wait that takes by weighing following traditional Chinese medicines by proportion relation mixes, Radix Salviae Miltiorrhizae 5.5Kg wherein, Rhizoma Corydalis 3Kg, Radix Angelicae Sinensis 0.5Kg, Radix Notoginseng 0.375Kg, Radix Paeoniae Rubra 4.5Kg, Pericarpium Citri Reticulatae Viride 0.5Kg, Radix Aucklandiae 3Kg, eupolyphaga 2Kg, Borneolum Syntheticum 0.125Kg.Drying and be ground into granularity after mixing under aseptic condition is 120 purpose powder, is distributed into capsule then, and every capsules is equipped with medicamental pulverata 0.3g.
The present invention also can be made into tablet or pill certainly based on capsule preparations, and embodiment 1 is an optimization formula.The commodity of the Chinese medicine preparation of reducing swelling and alleviating pain provided by the present invention are called " reducing swelling and alleviating pain pellet ".
Claims (2)
1. the Chinese medicine preparation of a reducing swelling and alleviating pain, it is characterized in that raw material composition and the weight proportion thereof of making this effective ingredient are: Radix Salviae Miltiorrhizae 4.5-5.5kg, Rhizoma Corydalis 2-3kg, Radix Angelicae Sinensis 0.5kg, Radix Notoginseng 0.375kg, Radix Paeoniae Rubra 4.5-5.5kg, Pericarpium Citri Reticulatae Viride 0.5kg, Radix Aucklandiae 2-3kg, eupolyphaga 2-3kg, Borneolum Syntheticum 0.125kg.
2. the Chinese medicine preparation of reducing swelling and alleviating pain according to claim 1, be characterised in that the raw material of making this effective ingredient is formed and weight proportion is: Radix Salviae Miltiorrhizae 5kg, Rhizoma Corydalis 2.5kg, Radix Angelicae Sinensis 0.5kg, Radix Notoginseng 0.375kg, Radix Paeoniae Rubra 5kg, Pericarpium Citri Reticulatae Viride 0.5kg, Radix Aucklandiae 2.5kg, eupolyphaga 2.5kg, Borneolum Syntheticum 0.125kg.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100171818A CN101612233B (en) | 2009-07-31 | 2009-07-31 | Chinese medicine preparation for detumescence and analgesia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100171818A CN101612233B (en) | 2009-07-31 | 2009-07-31 | Chinese medicine preparation for detumescence and analgesia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101612233A true CN101612233A (en) | 2009-12-30 |
| CN101612233B CN101612233B (en) | 2011-04-06 |
Family
ID=41492240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009100171818A Expired - Fee Related CN101612233B (en) | 2009-07-31 | 2009-07-31 | Chinese medicine preparation for detumescence and analgesia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101612233B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103830392A (en) * | 2014-03-19 | 2014-06-04 | 胶州市人民中医医院 | Swelling-diminishing pain-relieving medicine and preparation method thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1241419A (en) * | 1998-07-02 | 2000-01-19 | 袁方 | Fangzheng fracture-setting pain relieving ointment |
-
2009
- 2009-07-31 CN CN2009100171818A patent/CN101612233B/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103830392A (en) * | 2014-03-19 | 2014-06-04 | 胶州市人民中医医院 | Swelling-diminishing pain-relieving medicine and preparation method thereof |
| CN103830392B (en) * | 2014-03-19 | 2016-01-20 | 胶州市人民中医医院 | A kind of reducing swelling and alleviating pain medicine and preparation method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101612233B (en) | 2011-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101366892A (en) | Chinese medicinal composition for treating menorrhalgia | |
| CN104826016B (en) | A kind of pharmaceutical composition and its preparation method and application for treating the proliferation of mammary gland | |
| CN101711847B (en) | Oral traditional Chinese medicine preparation for treating melancholia and anxiety neurosis | |
| CN106421537A (en) | Traditional Chinese medicinal composition for treating gout and preparation method of traditional Chinese medicinal composition | |
| CN101199796B (en) | External antidiarrhoeal medicament, preparing method and function thereof | |
| CN104922299A (en) | Traditional Chinese medicine healthcare oral liquid used for preventing and treating diabetic retinopathy | |
| CN102526635B (en) | Medicament for treating premenstrual stress syndrome and preparation method thereof | |
| CN101912567B (en) | Chinese medicinal prescription for treating chronic myocarditis | |
| CN104547633B (en) | A kind of Chinese medicine composition for treating cervical spondylopathy and preparation method thereof | |
| CN103272159B (en) | Chinese herbal preparation used for treating consumptive disease and preparation method thereof | |
| CN102309613A (en) | Traditional Chinese medicine (TCM) prescription for treating lumbar muscle strain | |
| CN102008551A (en) | Medicinal composition for treating pains of necks, shoulders and arms and preparation method and application thereof | |
| CN1583003A (en) | Pillows for mastosis, e.g., hyperplasia, tumours and other diseases | |
| CN104840871A (en) | Traditional Chinese medicine for treating alcoholic liver injury | |
| CN101804189A (en) | Drug for treating primary dysmenorrhea | |
| CN101658636B (en) | Chinese medical composition for treating coronary heart disease | |
| CN101496892A (en) | Oral Chinese patent medicine for treating cardiovascular disease | |
| CN101491612B (en) | Medicine for treating mammary hyperplasia and early breast cancer | |
| CN101612233B (en) | Chinese medicine preparation for detumescence and analgesia | |
| CN103385963B (en) | Chinese medicine preparation for treating angina pectoris caused by coronary heart disease | |
| CN103272111A (en) | Traditional Chinese medicine liquor for treating toothache | |
| CN105878454A (en) | Pharmaceutical composition for treating apoplectic hemiplegia and rheumatic arthralgia and preparation method of pharmaceutical composition | |
| CN102225155B (en) | Medicament composition for treating pulmonary fibrosis | |
| CN102727773B (en) | Traditional Chinese medicinal capsule for treating blood mucoviscidosis | |
| CN101269191B (en) | Externally applied medicament for treating hepatopathy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110406 Termination date: 20110731 |